MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Avinger P/E Ratio 2011-2026 | AVGR
Annual P/E Ratio Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.142 | -0.0781 | -2.44 | -3.78 | -0.229 | -0.128 | -0.0974 | -0.738 | -3.48 | -4.16 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0781 | -4.16 | -1.53 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-86.3 | $ 33.91 | 3.99 % | $ 1.5 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-2.07 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-54.8 | $ 6.93 | 0.87 % | $ 498 M |  Israel |
 |
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
-0.0641 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | USA |
 |
Delcath Systems
DCTH
|
-14.2 | $ 9.27 | 1.64 % | $ 264 M | USA |
 |
Apyx Medical Corporation
APYX
|
-2.44 | $ 3.73 | -2.48 % | $ 129 M | USA |
 |
Alphatec Holdings
ATEC
|
-9.58 | $ 13.33 | 1.76 % | $ 1.91 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-3.16 | $ 4.92 | 3.15 % | $ 183 M |  France |
 |
BIOLASE
BIOL
|
-0.00929 | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
23.2 | $ 23.5 | 0.82 % | $ 199 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 260.94 | -10.77 % | $ 7.36 B | USA |
 |
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
0.000061 | $ 37.29 | -0.59 % | $ 5.56 K | USA |
 |
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
14.6 | $ 42.01 | 0.82 % | $ 1.3 B | USA |
 |
Boston Scientific Corporation
BSX
|
84 | $ 74.9 | 1.05 % | $ 110 B | USA |
 |
Abbott Laboratories
ABT
|
17.5 | $ 111.88 | 0.37 % | $ 195 B | USA |
 |
Cardiovascular Systems
CSII
|
-15.9 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-0.813 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.6 | $ 13.66 | 4.75 % | $ 369 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | USA |
 |
InMode Ltd.
INMD
|
7.91 | $ 14.25 | -0.35 % | $ 1.13 B | Israel |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 100.17 | 0.33 % | $ 1.27 B | USA |
 |
Integer Holdings Corporation
ITGR
|
38.2 | $ 85.09 | -0.32 % | $ 2.86 B | USA |
 |
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
-6.05 | $ 1.46 | 2.46 % | $ 57.1 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-0.108 | - | - | $ 10.2 M | USA |
 |
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.0096 | - | -0.97 % | $ 54.4 M | USA |
 |
Penumbra
PEN
|
744 | $ 340.01 | 0.38 % | $ 13.1 B | USA |
 |
FONAR Corporation
FONR
|
6.85 | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
Insulet Corporation
PODD
|
47.1 | $ 248.55 | 3.21 % | $ 17.4 B | USA |
 |
Profound Medical Corp.
PROF
|
-7.49 | $ 6.34 | 1.69 % | $ 180 M | Canada |
 |
Globus Medical
GMED
|
111 | $ 88.93 | 1.96 % | $ 12.1 B | USA |
 |
Sintx Technologies
SINT
|
-0.0226 | $ 2.77 | 1.84 % | $ 10.3 M | USA |
 |
Sensus Healthcare
SRTS
|
11.5 | $ 3.77 | -18.92 % | $ 61.5 M | USA |